Fatalities associated with the administration of this agent have occurred due to severe reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.
Fansidar prophylaxis must be discontinued at the first appearance of skin rash, if a significant reduction in the count of any formed blood elements is noted, or upon the occurrence of active bacterial or fungal infection.